HemaSphere
(Aug 2023)
PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
- Melissa Djodikromo,
- Charlotte Bekker,
- Rosella Hermens,
- Yolba Smit,
- Tim Govers,
- Bart van den Bemt,
- Nicole Blijlevens
Affiliations
- Melissa Djodikromo
- 1 Radboud University Medical Center, Haematology, Nijmegen, The Netherlands
- Charlotte Bekker
- 2 Radboud university medical center, Pharmacy, Nijmegen, The Netherlands
- Rosella Hermens
- 3 Radboud university medical center, Scientific Institute for Quality of Healthcare, Nijmegen, The Netherlands
- Yolba Smit
- 1 Radboud University Medical Center, Haematology, Nijmegen, The Netherlands
- Tim Govers
- 4 Radboud university medical center, Operating rooms, Nijmegen, The Netherlands
- Bart van den Bemt
- 5 Sint Maartenskliniek, Pharmacy, Nijmegen, The Netherlands
- Nicole Blijlevens
- 1 Radboud University Medical Center, Haematology, Nijmegen, The Netherlands
- DOI
-
https://doi.org/10.1097/01.HS9.0000974728.72592.7a
- Journal volume & issue
-
Vol. 7
p.
e725927a
WeChat QR code